These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35292850)

  • 1. The preventive care of medication-related osteonecrosis of the jaw (MRONJ): a position paper by Italian experts for dental hygienists.
    Mauceri R; Coniglio R; Abbinante A; Carcieri P; Tomassi D; Panzarella V; Di Fede O; Bertoldo F; Fusco V; Bedogni A; Campisi G
    Support Care Cancer; 2022 Aug; 30(8):6429-6440. PubMed ID: 35292850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020.
    Campisi G; Mauceri R; Bertoldo F; Bettini G; Biasotto M; Colella G; Consolo U; Di Fede O; Favia G; Fusco V; Gabriele M; Lo Casto A; Lo Muzio L; Marcianò A; Mascitti M; Meleti M; Mignogna MD; Oteri G; Panzarella V; Romeo U; Santarelli A; Vescovi P; Marchetti C; Bedogni A
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32824826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
    Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
    Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective study on the incidence of medication-related osteonecrosis of the jaws (MRONJ) associated with different preventive dental care modalities.
    Bacci C; Cerrato A; Bardhi E; Frigo AC; Djaballah SA; Sivolella S
    Support Care Cancer; 2022 Feb; 30(2):1723-1729. PubMed ID: 34580783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases.
    Otto S; Pautke C; Van den Wyngaert T; Niepel D; Schiødt M
    Cancer Treat Rev; 2018 Sep; 69():177-187. PubMed ID: 30055439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Dental Management of Patients at Risk of Medication-Related Osteonecrosis of the Jaw: New Paradigm of Primary Prevention.
    Di Fede O; Panzarella V; Mauceri R; Fusco V; Bedogni A; Lo Muzio L; Sipmo Onj Board ; Campisi G
    Biomed Res Int; 2018; 2018():2684924. PubMed ID: 30306086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and treatment of oral adverse effects of antiresorptive medications for osteoporosis - A position paper of the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Stomatology and Oral Pathology (Sobep), and Brazilian Association for Bone Evaluation and Osteometabolism (Abrasso).
    Madeira M; Rocha AC; Moreira CA; Aguiar ÁMM; Maeda SS; Cardoso AS; de Moura Castro CH; D'Alva CB; Silva BCC; Ferraz-de-Souza B; Lazaretti-Castro M; Bandeira F; Torres SR
    Arch Endocrinol Metab; 2021 May; 64(6):664-672. PubMed ID: 34033275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
    Owosho AA; Liang STY; Sax AZ; Wu K; Yom SK; Huryn JM; Estilo CL
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current knowledge regarding medication-related osteonecrosis of the jaw among different health professionals.
    Miranda-Silva W; Montezuma MA; Benites BM; Bruno JS; Fonseca FP; Fregnani ER
    Support Care Cancer; 2020 Nov; 28(11):5397-5404. PubMed ID: 32144584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Medication-Related Osteonecrosis of the Jaw (MRONJ) in Terms of Staging and Treatment Strategies by Dental Students at Different Educational Levels.
    Heimes D; Mark NA; Kuchen R; Pabst A; Becker P; Kyyak S; Thiem DGE; Schulze R; Kämmerer PW
    Medicina (Kaunas); 2023 Jan; 59(2):. PubMed ID: 36837455
    [No Abstract]   [Full Text] [Related]  

  • 11. Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?
    Soutome S; Hayashida S; Funahara M; Sakamoto Y; Kojima Y; Yanamoto S; Umeda M
    PLoS One; 2018; 13(7):e0201343. PubMed ID: 30048523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review.
    Kawahara M; Kuroshima S; Sawase T
    Int J Implant Dent; 2021 May; 7(1):47. PubMed ID: 33987769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prevention of Medication-related Osteonecrosis of the Jaw.
    Poxleitner P; Engelhardt M; Schmelzeisen R; Voss P
    Dtsch Arztebl Int; 2017 Feb; 114(5):63-69. PubMed ID: 28241916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporosis therapy in patients with inflammatory rheumatic diseases and osteonecrosis of the jaw.
    Schwaneck EC; Streit A; Krone M; Hartmann S; Müller-Richter U; Kübler AC; Gadeholt O; Schmalzing M; Tony HP; Brands RC
    Z Rheumatol; 2020 Mar; 79(2):203-209. PubMed ID: 30796524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceptions and attitudes of patients towards medication-related osteonecrosis of the jaw (MRONJ): a qualitative study in England.
    Sturrock A; Preshaw PM; Hayes C; Wilkes S
    BMJ Open; 2019 Mar; 9(3):e024376. PubMed ID: 30833319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication-related osteonecrosis of the jaw: knowledge and perceptions of medical professionals on the usage of bone modifying agents and dental referrals.
    Acharya S; Patil V; Ravindranath V; Kudva A; Nikhil K
    J Med Life; 2022 Mar; 15(3):368-373. PubMed ID: 35449990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?
    Giovannacci I; Meleti M; Manfredi M; Mortellaro C; Greco Lucchina A; Bonanini M; Vescovi P
    J Craniofac Surg; 2016 May; 27(3):697-701. PubMed ID: 27092912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment.
    Nicolatou-Galitis O; Schiødt M; Mendes RA; Ripamonti C; Hope S; Drudge-Coates L; Niepel D; Van den Wyngaert T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Feb; 127(2):117-135. PubMed ID: 30393090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of dental care providers in the management of patients prescribed bisphosphonates: brief clinical guidance.
    Abed HH; Al-Sahafi EN
    Gen Dent; 2018; 66(3):18-24. PubMed ID: 29714695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS.
    Anastasilakis AD; Pepe J; Napoli N; Palermo A; Magopoulos C; Khan AA; Zillikens MC; Body JJ
    J Clin Endocrinol Metab; 2022 Apr; 107(5):1441-1460. PubMed ID: 34922381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.